Clinical trial
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating…
NCT00499616 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00499616 |
|---|---|
| Title | Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma |
| Official title | Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, topotecan hydrochloride, Isotretinoin, Surgery, Filgrastim |
| Enrollment | 464 |
| Start date | Oct 8, 2007 |
| Primary completion | Jun 30, 2014 |
| Completion | Jun 30, 2021 |
| First posted | Jul 11, 2007 |
| Last update posted | Jul 6, 2021 |
| Countries | Australia, Canada, Netherlands, New Zealand, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: